These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25354110)

  • 1. Romancing the spliceosome to fight spinal muscular atrophy.
    Swoboda KJ
    N Engl J Med; 2014 Oct; 371(18):1752-4. PubMed ID: 25354110
    [No Abstract]   [Full Text] [Related]  

  • 2. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy.
    Naryshkin NA; Weetall M; Dakka A; Narasimhan J; Zhao X; Feng Z; Ling KK; Karp GM; Qi H; Woll MG; Chen G; Zhang N; Gabbeta V; Vazirani P; Bhattacharyya A; Furia B; Risher N; Sheedy J; Kong R; Ma J; Turpoff A; Lee CS; Zhang X; Moon YC; Trifillis P; Welch EM; Colacino JM; Babiak J; Almstead NG; Peltz SW; Eng LA; Chen KS; Mull JL; Lynes MS; Rubin LL; Fontoura P; Santarelli L; Haehnke D; McCarthy KD; Schmucki R; Ebeling M; Sivaramakrishnan M; Ko CP; Paushkin SV; Ratni H; Gerlach I; Ghosh A; Metzger F
    Science; 2014 Aug; 345(6197):688-93. PubMed ID: 25104390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular disorders: Beefing up the right splice variant to treat spinal muscular atrophy.
    Cully M
    Nat Rev Drug Discov; 2014 Oct; 13(10):725. PubMed ID: 25270954
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular biology. A splicing magic bullet.
    Vigevani L; Valcárcel J
    Science; 2014 Aug; 345(6197):624-5. PubMed ID: 25104373
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy.
    Woll MG; Qi H; Turpoff A; Zhang N; Zhang X; Chen G; Li C; Huang S; Yang T; Moon YC; Lee CS; Choi S; Almstead NG; Naryshkin NA; Dakka A; Narasimhan J; Gabbeta V; Welch E; Zhao X; Risher N; Sheedy J; Weetall M; Karp GM
    J Med Chem; 2016 Jul; 59(13):6070-85. PubMed ID: 27299569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alternative splicing and the cure of spinal muscular atrophy].
    Marasco LE; Stigliano J; Kornblihtt AR
    Medicina (B Aires); 2019; 79(Spec 6/1):582-586. PubMed ID: 31864230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMN in spinal muscular atrophy and snRNP biogenesis.
    Coady TH; Lorson CL
    Wiley Interdiscip Rev RNA; 2011; 2(4):546-64. PubMed ID: 21957043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy.
    Zhao X; Feng Z; Ling KK; Mollin A; Sheedy J; Yeh S; Petruska J; Narasimhan J; Dakka A; Welch EM; Karp G; Chen KS; Metzger F; Ratni H; Lotti F; Tisdale S; Naryshkin NA; Pellizzoni L; Paushkin S; Ko CP; Weetall M
    Hum Mol Genet; 2016 May; 25(10):1885-1899. PubMed ID: 26931466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in therapeutic development for spinal muscular atrophy.
    Howell MD; Singh NN; Singh RN
    Future Med Chem; 2014 Jun; 6(9):1081-99. PubMed ID: 25068989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using mini-genes to identify factors that modulate alternative splicing.
    Morse R; Todd AG; Young PJ
    Methods Mol Biol; 2012; 867():349-62. PubMed ID: 22454072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy.
    Ratni H; Karp GM; Weetall M; Naryshkin NA; Paushkin SV; Chen KS; McCarthy KD; Qi H; Turpoff A; Woll MG; Zhang X; Zhang N; Yang T; Dakka A; Vazirani P; Zhao X; Pinard E; Green L; David-Pierson P; Tuerck D; Poirier A; Muster W; Kirchner S; Mueller L; Gerlach I; Metzger F
    J Med Chem; 2016 Jul; 59(13):6086-100. PubMed ID: 27299419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides.
    Aartsma-Rus A
    Nucleic Acid Ther; 2017 Apr; 27(2):67-69. PubMed ID: 28346110
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
    Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
    Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA regulation: A patch for a splice.
    Miller BL
    Nat Chem Biol; 2015 Jul; 11(7):454-5. PubMed ID: 26083069
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds.
    Cherry JJ; Osman EY; Evans MC; Choi S; Xing X; Cuny GD; Glicksman MA; Lorson CL; Androphy EJ
    EMBO Mol Med; 2013 Jul; 5(7):1103-18. PubMed ID: 23740718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense-based therapy for the treatment of spinal muscular atrophy.
    Rigo F; Hua Y; Krainer AR; Bennett CF
    J Cell Biol; 2012 Oct; 199(1):21-5. PubMed ID: 23027901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.
    Sivaramakrishnan M; McCarthy KD; Campagne S; Huber S; Meier S; Augustin A; Heckel T; Meistermann H; Hug MN; Birrer P; Moursy A; Khawaja S; Schmucki R; Berntenis N; Giroud N; Golling S; Tzouros M; Banfai B; Duran-Pacheco G; Lamerz J; Hsiu Liu Y; Luebbers T; Ratni H; Ebeling M; Cléry A; Paushkin S; Krainer AR; Allain FH; Metzger F
    Nat Commun; 2017 Nov; 8(1):1476. PubMed ID: 29133793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P; Baklouti F; Binda O
    Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.